Effect of poly-hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts

Abstract

The objective of the work was to investigate the effects of a range of poly-hydroxy aliphatic esters (poly-lactide (PLA) and poly-lactide-co-glycolide (PLGA)) of different molecular weight and composition on the release and stability of the amphoteric drug amoxycillin. The effect of this amphoteric drug on the extent and kinetics of polymer degradation was also investigated. The polymers were used to prepare drug-free and drug-loaded cylindrical discs. Drug release profiles were determined while changes in polymer composition were monitored by weight loss and molecular weight change. The extent of drug release was highly dependant on polymer molecular weight and composition, with earlier complete release occurring with the lower molecular weight and lower lactide containing polymers. A larger proportion of drug was released by polymer degradation control with the higher lactide containing polymer. The proportion of drug released intact was influenced by the polymer molecular weight, with a greater proportion of intact drug being released from the higher molecular weight systems. The inclusion of amoxycillin influenced polymer degradation and resulted in slower polymer hydrolysis. Model parameters obtained for polymer degradation indicated that this retardation effect increased with increasing lactide content of the polymer. The results suggest that small amounts of amoxycillin or its degradation products may bind or cross link with the polymers, thus retarding their degradation.